Health Trials

Refractory Rheumatoid Arthritis Ra

1

Review clinical trials related to Refractory Rheumatoid Arthritis Ra. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

A Basket Trial of Refractory Rheumatoid Arthritis (RA), Sjögren's Disease (SjD), Idiopathic Inflammatory Myopathies (IIMs) and Systemic Sclerosis (SSc) subjects to evaluate the safety and efficacy of AlloNK, a non-genetically modified allogeneic NK cell, in combination with rituximab.

Participants needed: 90
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Artiva Biotherapeutics, Inc.Updated: May 22, 2026Locations: 52
Eligibility criteria

Documented diagnosis of RA, meeting the 2010 ACR/EULAR classification criteria. [+14]

Read more